Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Kidney symbols : GSK save search
Kidney Transplantation Therapeutics Market 2023; USD 643.15 million Growth Expected between 2023 and 2028, Rising prevalence of CKD and renal impairments to boost growth - Technavio
Published: 2024-01-29 (Crawled : 18:00) - prnewswire.com
ALPMF | News | $9.5 43.47% 1.2K
|
Health Technology
|
| O: 1.76%
H: 0.0%
C: 0.0%
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 2.93%
H: 0.0%
C: -1.15%
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: -3.53%
H: 3.49%
C: 3.4%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.59%
H: 0.49%
C: 0.41%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.26%
H: 0.13%
C: -0.18%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.19%
H: 0.46%
C: 0.43%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
kidney renal expected million therapeutics growth market
Kidney stones market size to grow by USD 566.78 million between 2022 and 2027; Growth driven by rising incidence of urolithiasis - Technavio
Published: 2023-03-30 (Crawled : 03:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: -1.99%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.0%
H: 0.65%
C: 0.6%
kidney growth market
Kidney Stones Market Size to Grow by USD 416.09 Mn | Growing Popularity of Digital Flexible Ureteroscopes to Boost Growth | Technavio
Published: 2022-01-25 (Crawled : 05:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 2.24%
H: 0.09%
C: 0.09%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.83%
H: 1.16%
C: 0.82%
BHC | $8.56 0.35% 0.0% 2M
|
Health Technology
|
| O: -1.22%
H: 1.69%
C: 0.0%
growing growth kidney stones kidney
Global End Stage Renal Disease Market 2021-2027: Low Maintenance Dialysis Equipment and Artificial Kidneys are Expected to Drive Market Growth
Published: 2022-01-11 (Crawled : 17:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 0.55%
H: 0.0%
C: 0.0%
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -3.41%
H: 5.99%
C: 1.1%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.84%
H: 0.0%
C: 0.0%
MDT | $80.38 -1.12% 0.0% 5M
|
Health Technology
|
| O: 0.48%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.37%
H: 0.0%
C: 0.0%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: -0.41%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.58%
H: 0.0%
C: 0.0%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.71%
H: 0.0%
C: 0.0%
kidney disease dialysis
GSK announces positive Phase III efficacy and safety data for daprodustat in patients with anaemia due to chronic kidney disease
Published: 2021-11-05 (Crawled : 22:00) - biospace.com/
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 3.11%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
disease positive kidney
Insights on the Kidney Cancer Diagnostics and Therapeutics Global Market to 2026 - Key Motivators, Restraints and Opportunities
Published: 2021-08-05 (Crawled : 16:00) - prnewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: -0.42%
H: 0.31%
C: 0.13%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.48%
H: 0.24%
C: 0.24%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.69%
H: 0.37%
C: 0.34%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.14%
H: 0.3%
C: 0.22%
EXEL | $23.7 1.76% 1.73% 1.5M
|
Health Technology
|
| O: 0.0%
H: 2.03%
C: 1.25%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 1.48%
H: 0.46%
C: 0.43%
ADAP | $1.085 -4.83% -5.07% 780K
|
Health Technology
|
| O: 0.58%
H: 4.05%
C: 2.02%
cancer diagnostics kidney diagnostic
Worldwide Chronic Kidney Disease Drugs Industry to 2029 - High prevalence of Chronic Kidney Disease is Driving Growth
Published: 2021-03-31 (Crawled : 20:00) - prnewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.19%
H: 0.41%
C: 0.0%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -1.06%
H: 0.76%
C: 0.14%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.17%
H: 0.48%
C: 0.2%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: 0.37%
H: 0.49%
C: -1.11%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.22%
H: 0.51%
C: 0.02%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -0.22%
H: 0.35%
C: -0.16%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.37%
H: 0.11%
C: -0.22%
disease drug growth kidney
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.